ghk-cu fda approved drug status adds non-injectable back to Category 1. FDA Thursday re-added non-injectable GHK-Cu to Category 1 of the 503A bulks process after the nomination was withdrawn from further review. Injectable GHK-Cu remains GHK-Cu Facial Serum | Empower
Description
Deficiencies in these vitamins can lead to significant neurological and psychiatric conditions, including Wernicke Korsakoff syndrome, Parkinsons disease, and various mental illnesses

The FDA has not evaluated this product for therapeutic purposes

But many have little or no high-quality human evidence for the claims being made online
At SCULPT, we design personalized peptide protocols that help your body do what it was built to do: restore balance, accelerate recovery, and operate at peak performance
